Publications by authors named "Jason Efstathiou"

Claim this Profile
P
Predicting Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: A Step Towards More Personalized Treatment.
Jonathan E Leeman, Jason A Efstathiou

Eur Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115).
Daniel A Hamstra, James J Dignam, Deborah W Bruner, M Dror Michaelson, François Bachand, Jason A Efstathiou

Int J Radiat Oncol Biol Phys· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSA density as a dynamic prognostic marker of biopsy grade progression during active surveillance.
Andrew Gusev, Florian Rumpf, Dimitar Zlatev, Jeffrey K Twum-Ampofo, John L Gore, Jason Efstathiou

Urol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer.
Sebastian Medina, Naoto Tokuyama, Kamal Hammouda, Tilak Pathak, Tuomas Mirtti, Jason A Efstathiou

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor splice variant expression and prostate cancer recurrence after salvage therapy.
David J Konieczkowski, Keisuke Otani, Zoe Guan, Michael R Drumm, Yukako Otani, Jason A Efstathiou

NPJ Precis Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.
Rana R McKay, Sumanta Pal, Wanling Xie, David Aggen, Laurence Albiges, Jason Efstathiou

CA Cancer J Clin· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials.
Todd M Morgan, Yi Ren, Siyi Tang, Wouter Zwerink, Emmalyn Chen, Jason A Efstathiou

Eur Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Metastasis-Targeted External Beam Radiation Therapy With Lu-PSMA-617 in Patients With Advanced Castration-Resistant Prostate Cancer.
Sedra Mohammadi, Isabella R Pompa, Veronica Haberman, Bashar Kako, Richard J Lee, Jason A Efstathiou

Pract Radiat Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review and Meta-analysis on Perioperative Stenting/Dwell Time and Postoperative Outcomes in Patients Undergoing Radical Cystectomy and Urinary Diversion for Bladder Cancer.
Mithun Kailavasan, Alberto Martini, Max Bruins, Albert Carrion, Richard Cathomas, Jason A Efstathiou

Eur Urol Focus· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postprostatectomy.
Himanshu R Lukka, Stephanie L Pugh, William U Shipley, Pierre P Major, Oliver Sartor, Jason A Efstathiou

Int J Radiat Oncol Biol Phys· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.
Andrea Necchi, Matthew D Galsky, Nazli Dizman, David H Aggen, Neeraj Agarwal, Jason A Efstathiou

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the 2024 National Association for Proton Therapy, Proton Collaborative Group, and Particle Therapy Co-operative Group-North America Proton Therapy Research Forum: Refining Particle Therapy Trial Design and Identifying High-need Areas for Continued Investigation.
J Isabelle Choi, Anita Mahajan, Michael G Barron, Jeffrey D Bradley, Michael D Chuong, Jason Efstathiou

Int J Radiat Oncol Biol Phys· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-Analysis.
Nicholas G Zaorsky, Yilun Sun, Abdenour Nabid, Almudena Zapatero, Michel Bolla, Jason A Efstathiou

JAMA Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular tumor volume on PSMA PET/CT is an independent imaging biomarker associated with progression-free survival in patients with oligorecurrent prostate cancer.
Monica Cheng, Umar Mahmood, Nathaniel D Mercaldo, Shadi A Esfahani, Thomas Ng, Jason A Efstathiou

Am J Nucl Med Mol Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024.
Ursula M Vogl, Sara Merler, Antonio Angrisani, Fabio Turco, Ian D Davis, Jason A Efstathiou

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy.
Emily Chan, Stephanie L Pugh, Jeffry P Simko, Felix Feng, William U Shipley, Jason A Efstathiou

Prostate· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering Committee.
Valeria Panebianco, Alberto Briganti, Jason A Efstathiou, Samuel J Galgano, Lyndon Luk

Eur Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of cone beam computed tomography post-processing methods for online adaptive proton therapy of prostate cancer.
Mislav Bobić, Daniel H Bushe, Hoyeon Lee, Brian A Winey, Jason A Efstathiou

Phys Imaging Radiat Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data.
Sarah Burdett, David J Fisher, Jayne F Tierney, Adrian D Cook, Daniel E Spratt, Jason A Efstathiou

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of MRI-derived features for biochemical recurrence after curative radiotherapy in prostate cancer.
Alexander Herold, Maximilian Pohl, Stephan M Korn, Michael Weber, Jason A Efstathiou

Abdom Radiol (NY)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation Therapy in the Management of Muscle-invasive Bladder Cancer with Carcinoma in Situ: Still a No Go?
Constance Huck, Vérane Achard, Jason Efstathiou, Julien Van Damme, Alexandre R Zlotta

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial.
Ryan M Phillips, James A Proudfoot, Elai Davicioni, Yang Liu, Daniel E Spratt, Jason A Efstathiou

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VI-RADS quality score: development and proposal of a scoring system by the American College of Radiology VI-RADS Steering Committee.
Sungmin Woo, Lyndon Luk, Valdair F Muglia, Alberto Briganti, Jason Efstathiou

Eur Radiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Francesco Montorsi, Giuseppe Rosiello, Pietro Scilipoti, Marco Moschini, and Andrea Salonia's Letter to the Editor re: Valeria Panebianco, Alberto Briganti, Jason Efstathiou, et al. The Role of Multiparametric Magnetic Resonance Imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in the Management of Patients with Bladder Cancer: Vision of the American College of Radiology VI-RADS Steering Committee. Eur Urol 2024;86:485-7.
Valeria Panebianco, Alberto Briganti, Jason Efstathiou, Samuel Galgano, Lyndon Luk

Eur Urol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Evolving Management of Radiorecurrent Prostate Cancer.
Jacob Pozin, Menal Bhandari, Luca Valle, Nicholas G Nickols, Amar U Kishan, Jason A Efstathiou

Semin Radiat Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis